Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12475080 | 0.73 | SMN1; SMN2 (0.47) | SMN1; SMN2 | |
| SCHEMBL9635649 | 0.69 | CA1 (0.40) | CA12CA1CA9 | |
| SCHEMBL197756 | 0.67 | — | — | |
| SCHEMBL1290379 | 0.67 | FGFR1 (0.37) | SMN1; SMN2CA1CA9 | |
| SCHEMBL11757970 | 0.63 | TSHR (0.34) | — | |
| SCHEMBL11757980 | 0.63 | TSHR (0.34) | — | |
| Bicarbonate SCHEMBL10505866 | 0.62 | TRIM24 (0.41) | SMN1; SMN2CA1CA9 | |
| SCHEMBL11135748 | 0.60 | TYMS (0.34) | — | |
| SCHEMBL168735 | 0.60 | PYGM (0.35) | CA1CA9 | |
| SCHEMBL1286030 | 0.60 | PYGM (0.35) | CA1CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11028121-B2 | Multisignal labeling reagents and processes and uses therefor | ENZO LIFE SCIENCES, INC. (US) | 2021-06-08 | — | — | US | disclosed |
| US-20200270297-A1 | MULTISIGNAL LABELING REAGENTS AND PROCESSES AND USES THEREFOR | ENZO LIFE SCIENCE, INC. (US) | 2020-08-27 | — | — | US | disclosed |
| US-10647740-B2 | Multisignal labeling reagents and processes and uses therefor | ENZO LIFE SCIENCE, INC. (US) | 2020-05-12 | — | — | US | disclosed |
| US-10640529-B2 | Multisignal labeling reagents and processes and uses therefor | ENZO LIFE SCIENCES, INC. (US) | 2020-05-05 | — | — | US | disclosed |
| EP-1489422-B1 | Multisignal labeling reagents, processes and uses therefor | ENZO LIFE SCIENCES INC (US) | 2018-06-06 | — | — | EP | disclosed |
| US-20180127455-A1 | MULTISIGNAL LABELING REAGENTS AND PROCESSES AND USES THEREFOR | Enzo Life Science, Inc., c/o Enzo Biochem, Inc. (US) | 2018-05-10 | — | — | US | disclosed |
| US-20180127456-A1 | MULTISIGNAL LABELING REAGENTS AND PROCESSES AND USES THEREFOR | Enzo Life Science, Inc., c/o Enzo Biochem, Inc. (US) | 2018-05-10 | — | — | US | disclosed |
| US-9884889-B2 | Multisignal labeling reagents and processes and uses therefor | ENZO LIFE SCIENCES, INC. (US) | 2018-02-06 | — | — | US | disclosed |
| US-20160025716-A1 | MULTISIGNAL LABELING REAGENTS AND PROCESSES AND USES THEREFOR | Enzo Life Science, Inc., c/o Enzo Biochem, Inc. (US) | 2016-01-28 | — | — | US | disclosed |
| US-9156986-B2 | Multisignal labeling reagents and processes and uses therefor | ENZO LIFE SCIENCES, INC. (US) | 2015-10-13 | — | — | US | disclosed |
| US-8389701-B2 | Multisignaling oligomeric or polymeric compositions comprising labeled moieties and binding partners | ENZO LIFE SCIENCES, INC. (US) | 2013-03-05 | — | — | US | disclosed |
| US-8389702-B2 | Multi-oligomeric or multi-polymeric compositions comprising labeled moieties and binding partners | ENZO LIFE SCIENCES, INC. (US) | 2013-03-05 | — | — | US | disclosed |
| WO-2012128898-A1 | MULTISIGNAL LABELING REAGENTS AND PROCESSES AND USES THEREFOR | ENZO LIFE SCIENCES, INC. (US) | 2012-09-27 | — | — | WO | disclosed |
| US-20110318788-A1 | Multisignal labeling reagents and processes and uses therefor | ENZO LIFE SCIENCES, INC., C/O ENZO BIOCHEM, INC. (US) | 2011-12-29 | — | — | US | disclosed |
| US-20110028692-A1 | Multisignaling oligomeric or polymeric compositions comprising labeled moieties and binding partners | ENZO LIFE SCIENCES, INC. C/O ENZO BIOCHEM, INC. (US) | 2011-02-03 | — | — | US | disclosed |
| US-20100324268-A1 | Multi-oligomeric or multi--polymeric compositions comprising labeled moieties and binding partners | ENZO LIFE SCIENCES, INC. C/O ENZO BIOCHEM, INC. (US) | 2010-12-23 | — | — | US | disclosed |
| US-20090258374-A1 | Multisignal Labeling Reagents, and Processes and Uses Therefor | ENZO LIFE SCIENCES, INC. | 2009-10-15 | — | — | US | disclosed |
| US-7514551-B2 | Multisignal labeling reagents, and processes and uses therefor | ENZO LIFE SCIENCES, INC. (US) | 2009-04-07 | — | — | US | disclosed |
| EP-1489422-A2 | Multisignal labeling reagents, processes and uses therefor | Enzo Life Sciences, Inc., c/o Enzo Biochem, Inc. (US) | 2004-12-22 | — | — | EP | disclosed |
| US-20040198971-A1 | Multisignal labeling reagents, and processes and uses therefor | ENZO LIFE SCIENCES, INC. | 2004-10-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10647740-B2 | Multisignal labeling reagents and processes and uses therefor | PCNA, LIG4, LIG1 | SMN1; SMN2 4478/4885CA12 4680/4885CA1 4780/4885 |
| US-20110318788-A1 | Multisignal labeling reagents and processes and uses therefor | PCNA, LIG4, LIG1 | SMN1; SMN2 4478/4885CA12 4680/4885CA1 4780/4885 |
| US-20040198971-A1 | Multisignal labeling reagents, and processes and uses therefor | HASPIN, HADHB, SPPL2B | SMN1; SMN2 4597/4885CA12 1303/4885CA1 2583/4885 |
| US-10640529-B2 | Multisignal labeling reagents and processes and uses therefor | PCNA, LIG4, LIG1 | SMN1; SMN2 4478/4885CA12 4680/4885CA1 4780/4885 |
| US-20110028692-A1 | Multisignaling oligomeric or polymeric compositions comprising labeled moieties and binding partners | PICALM, CLTB, PHAX | SMN1; SMN2 4025/4885CA12 2564/4885CA1 3016/4885 |
| US-20180127455-A1 | MULTISIGNAL LABELING REAGENTS AND PROCESSES AND USES THEREFOR | PCNA, LIG4, LIG1 | SMN1; SMN2 4478/4885CA12 4680/4885CA1 4780/4885 |
| US-20100324268-A1 | Multi-oligomeric or multi--polymeric compositions comprising labeled moieties and binding partners | PICALM, CLTB, PCBP1 | SMN1; SMN2 3665/4885CA12 2603/4885CA1 3176/4885 |
| US-20180127456-A1 | MULTISIGNAL LABELING REAGENTS AND PROCESSES AND USES THEREFOR | PCNA, LIG4, LIG1 | SMN1; SMN2 4478/4885CA12 4680/4885CA1 4780/4885 |
| US-11028121-B2 | Multisignal labeling reagents and processes and uses therefor | PCNA, LIG4, LIG1 | SMN1; SMN2 4478/4885CA12 4680/4885CA1 4780/4885 |
| US-20200270297-A1 | MULTISIGNAL LABELING REAGENTS AND PROCESSES AND USES THEREFOR | PCNA, LIG4, LIG1 | SMN1; SMN2 4478/4885CA12 4680/4885CA1 4780/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.